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Abstract
The short rib polydactyly syndromes (SRPS) are a heterogeneous group of autosomal recessive, 
perinatal-lethal skeletal disorders characterized primarily by short, horizontal ribs, short limbs, and 
poly-dactyly. Mutations in several genes affecting intraflagellar transport (IFT) cause SRPS but 
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they do not account for all cases. Here we identify additional SRPS genes and further unravel the 
functional basis for IFT. We perform whole exome sequencing and identify mutations in a new 
disease-producing gene, cytoplasmic dynein-2 light intermediate chain 1, DYNC2LI1, segregating 
with disease in three families. Using primary fibroblasts, we show that DYNC2LI1 is essential for 
dynein-2 complex stability and that mutations in DYNC2LI1 result in variable-length, including 
hyperelongated, cilia, Hedgehog pathway impairment, and ciliary IFT accumulations. The 
findings in this study expand our understanding of SRPS locus heterogeneity and demonstrate the 
importance of DYNC2LI1 in dynein-2 complex stability, cilium function, Hedgehog regulation, 
and skeletogenesis.
Introduction
The primary cilium is a microtubule-based projection on the surface of nearly every cell that 
acts as a concentrated signaling center for several pathways1. Defects in the formation or 
function of primary cilia cause a wide variety of disorders known as ciliopathies. As a 
testament to the importance of this organelle, ciliopathies collectively affect all major organ 
systems2, including the skeleton. Cilium assembly and function require intraflagellar 
transport (IFT), a system for bidirectional traffic into and out of this organelle. IFT depends 
on the microtubule motor protein activities of two multi-protein complexes3: IFT-B, the 
kinesin-2-driven anterograde complex, mediates base-to-tip transport, and IFT-A, the 
dynein-2-driven retrograde complex, mediates tip-to-base transport.
The SRPS are autosomal recessive, perinatal-lethal disorders. Radiographic abnormalities 
include very short, horizontal ribs, short limbs, and variable degrees of polydactyly. Other 
organ system abnormalities, particularly those affecting the heart and kidney, are frequently 
seen. SRPS are part of a spectrum of heterogeneous skeletal ciliopathies that include 
Asphyxiating Thoracic Dystrophy (ATD), Ellis van Creveld and Sensenbrenner syndromes. 
Mutations in the gene encoding the IFT-A cytoplasmic dynein-2 motor heavy chain, 
DYNC2H1 (MIM 603297), are the most common cause of both SRPS and ATD4, 5. 
Recently, mutations in several additional genes have been shown to cause SRPS: IFT806, 7 
(MIM 611263), WDR358, 9 (MIM 614091), WDR1910 (MIM 614376), NEK111, 12 (MIM 
263520), WDR3413, 14 (MIM 615633), IFT14015, 16 (MIM 266920), IFT17217 (MIM 
615630), WDR6018 (MIM 615462), and TTC21B19 (MIM 612014). Among the proteins 
encoded by the SRPS genes, WDR60 and WDR34 are intermediate chains of the DYNC2H1 
cytoplasmic dynein-2 complex, highlighting its importance in skeletal development20. Here 
we show that mutations in another member of the complex, DYNC2LI1, also cause SRPS, in 
part through loss of complex stability.
The IFT-A dynein-2 complex is composed of at least five components: the dynein heavy 
chain DYNC2H1 (DHC1b)21, 22, 23, the two intermediate chains WDR34 (DIC5/FAP133)24 
and WDR60 (FAP153)25, the light intermediate chain DYNC2LI1 (D1bLIC/D2LIC/LIC3/
XBX1)26, 27, 28, 29 and the LC8 light chain30. DYNC2LI1 was described as a novel dynein 
light intermediate chain based on its amino acid sequence, its ability to interact with 
DYNC2H1, and its localization to cilia26, 31. As an accessory chain binding to the base of 
the dynein-2 complex, DYNC2LI1 is likely involved in tethering the dynein-2 motor to 
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substrates such as vesicles and providing docking sites for cargo26, 31. It is essential for 
cilio-genesis and contains an X-box promoter that is recognized by the ciliary transcription 
factor RFX3/DAF-1928, 32. Recent studies have shown that DYNC2LI1 is essential for 
dynein-2 complex stability and its depletion in Trypansoma brucei and Chlamydomonas 
reinhardtii results in loss and mislocalization of DYNC2H124, 29, 33, 34. Furthermore, 
DYNC2LI1 mouse mutants result in lethality early in embryogenesis with developmental 
abnormalities characteristics of severe Hedgehog signaling defects35.
In this study, we identify mutations in DYNC2LI1 causing SRPS in three independent cases. 
We show that DYNC2LI1 is essential for dynein-2 complex stability, is expressed in the 
cartilage growth plate, and plays critical roles in the regulation of primary cilium length, 
retrograde IFT, and Hedgehog signaling. Analysis of SRPS-derived fibroblasts supports a 
role for DYNC2LI1 in cilia function and signaling and the findings highlight the importance 
of this gene and the dynein-2 complex in skeletogenesis.
Results
DYNC2LI1 mutations identified in SRPS cases
To identify additional genes that are essential for skeletal development, we used whole 
exome sequencing under an approved human subjects protocol and identified mutations in 
the dynein-2 light intermediate chain gene, DYNC2LI1, producing SRPS. Three probands 
from unrelated Caucasian families were identified by prenatal ultrasound and elective 
terminations were performed at 14, 19, and 22 weeks, respectively. In the prenatal period, 
ultrasound findings included shortened long bones, diminished chest circumferences for 
gestational age, and polydactyly. No other obvious organ system abnormalities were 
detected by ultrasound. Radiographic analyses showed polydactyly of the upper and lower 
extremities, a long narrow thorax with very short horizontal ribs, lack of ossification of 
some skeletal elements, and irregular metaphyseal borders with lateral spikes (Fig. 1). These 
findings are characteristic of SRPS and radiographically similar to SRPS cases described 
with DYNC2H1 and WDR34 mutations4, 13, 36.
In all three cases there was compound heterozygosity for mutations in DYNC2LI1 
(Supplementary Fig. 1). Two affected individuals, R01-013A and R03-303A, were 
heterozygous for changes in in-tron 12 (c.993+1G>A, c.993+3A>G) that are predicted to 
affect splicing (Table 1). RT-PCR analysis on RNA derived from fibroblasts from both 
fetuses demonstrated that both mutations resulted in in-frame skipping of exon 12 (Fig. 2a). 
R01-013A and R07-628A were both heterozygous for a point mutation causing the predicted 
amino acid p.Leu117Val substitution. This missense mutation occurs within a region 
conserved among the three mammalian dynein light intermediate chains (DLICs) and resides 
within an NTPase-related domain (Supplementary Fig. 2). This mutation may interfere with 
cargo-binding as it occurs within a homologous region that is required for cargo-binding in 
DYNC1LI137. However, of the three mammalian DLICs, only DYNC2LI1 interacts with the 
dynein-2 complex; the more closely related DYNC1LI1 and DYNC1LI2 are targeted to the 
non-ciliary cytoplasmic dynein-1, DYNC1H126, 38. Finally, the other heterozygous changes 
in R07-628A and R03-303A were nonsense mutations in exon 6 (p.Trp124Ter) and 13 
(p.Glu334Ter), respectively. Western blot analyses of fibroblast-derived lysates showed that 
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DYNC2LI1 is markedly reduced in R01-013A (c.993+1G>A; p.Leu117Val) and R07-628A 
(p.Trp124Ter; p.Leu117Val), indicating that these mutations likely lead to loss of 
DYNC2LI1 stability (Fig. 2b,c).
DYNC2LI1-mutant fibroblasts are depleted of DYNC2H1
DYNC2H1 and DYNC2LI1 are distinct components of the ciliary dynein-2 complex and 
studies in Chlamydomonas reinhardtii and Trypanosoma brucei show that loss of one results 
in loss or reduction of the other24, 29, 33, 34. To determine whether DYNC2H1 amounts were 
affected by the decrease in DYNC2LI1, we probed whole-cell lysates from SRPS cases and 
controls for DYNC2H1 and discovered near-total loss of protein (Fig. 3a). The amounts of 
the dynein-2 intermediate chain WDR34 and the heavy chain of the dynein-1 complex 
(DYNC1H1) were unchanged, indicating that the effects of the DYNC2LI1 mutations were 
specific to DYNC2H1. Immunofluorescence staining showed that WDR34 and the minimal 
remaining DYNC2H1 in SRPS cells localized to the basal bodies, similar to controls (Fig. 
3b). These results suggest that even though DYNC2LI1 is important for the stabilization of 
DYNC2H1, it is not essential for the recruitment of the dynein-2 complex to the 
pericentriolar region of basal bodies.
DYNC2LI1 is expressed in the developing human growth plate
While the dynein-2 complex is required for IFT in all ciliated cells of the body, the marked 
skeletal consequences of dynein-2 complex mutations suggest that the developing skeleton 
is very sensitive to reductions in its activity. Concordant with this hypothesis, transcriptional 
analysis by qRT-PCR showed that DYNC2LI1 was more highly expressed in bone compared 
with other embryonic tissues (bone, brain, cartilage, heart, liver, lung, placenta and thymus) 
(Supplementary Fig. 3). Furthermore, immunohistochemistry of human cartilage growth 
plate revealed DYNC2LI1 expression in the perichondrium, periosteum and primary 
spongiosa of bone (Fig. 4). Similarly, immunohistochemistry of DYNC2H1 and WDR34 
showed an overlapping expression pattern (Fig. 4). Together, these expression studies 
support a role for DYNC2LI1 and the dynein-2 complex in human skeletal development.
SRPS fibroblasts exhibit loss of ciliary length control
To investigate whether mutations in DYNC2LI1 affect ciliogenesis and/or IFT, we quantified 
the fraction of ciliated cells, measured cilia length and probed SRPS and control fibroblasts 
for a number of ciliary components. The percentage of ciliated cells was only slightly 
reduced between SRPS and control cells (Fig. 5b). However, we found that primary cilia 
length was highly variable in SRPS fibroblasts, with a substantial increase in the number of 
hyperelongated cilia up to 20 μm in length (Fig. 5a,c,d). To determine if the ciliary length 
variation observed in SRPS cells resulted from decreased amounts of DYNC2LI1, we 
performed RNAi against DYNC2LI1 in hTERT-RPE1 (retinal epithelial) cells. DYNC2LI1-
knockdown led to significantly increased variation in cilia length, thus reproducing the 
phenotype observed in SRPS fibroblasts (Supplementary Fig. 4a,b). To test for phenotypic 
rescue, we expressed wild type DYNC2LI1 in SRPS cells. As shown in Fig. 5c,d, 
transfection of DYNC2LI1 into SRPS fibroblasts reduced ciliary length variation and 
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restored length to control values. We therefore conclude that DYNC2LI1 and the dynein-2 
complex play an important role in the regulation of primary cilia length.
IFT components accumulate in DYCN2LI1-mutant cilia
The IFT-B components, IFT88 and TRAF3IP1, and the IFT-B kinesin motor, KIF3A, 
localized strongly to the base of the cilia and weakly along the axoneme in control cells, as 
observed by others39 (Fig. 6a). Consistent with defective retrograde transport in SRPS 
fibroblasts, IFT88, TRAF3IP1, and KIF3A all accumulated near the cilia tip. More 
specifically, three to four fold more IFT88 was retained in the axonemes of DYNC2LI1-
mutant cilia than in controls (Fig 6c). RNAi-knockdown of DYNC2LI1 in RPE1 cells 
replicated this finding by increasing the ratio of IFT88 retained in the primary cilium body 
relative to the proximal end by three fold (Supplementary Fig. 4c,d). In addition, we were 
able to reduce this ratio in SRPS fibroblasts by expressing wild type DYNC2LI1 (Fig. 6b,c). 
Our results demonstrate that loss of DYNC2LI1 markedly impairs retrograde IFT and leads 
to the accumulation of IFT proteins within the primary cilium.
SMO inappropriately enters the cilia of SRPS fibroblasts
Hedgehog signaling requires intact cilia and IFT; not surprisingly, many IFT mutants 
display defects in this pathway40. To determine if DYNC2LI1 mutations affect Hedgehog 
signaling, we examined the localization of SMO and GLI3 in SMO agonist (SAG)-
stimulated and unstimulated fibroblasts from SRPS cases and controls. While the 
localization of GLI3 did not differ between SRPS and control cells (Fig. 7a), we detected 
SMO along the length of cilia of unstimulated DYNC2LI1-mutant cells (Fig. 7b,c). In 
contrast, SMO was only observed in the cilia of control cells upon stimulation. Similar to 
findings in DYNC2H1 mouse mutants41, these observations suggest that DYNC2LI1 and the 
activity of the dynein-2 complex play an important role in preventing SMO from entering 
cilia in the absence of Hedgehog stimulation.
DYNC2LI1 mutants exhibit reduced GLI3 processing
To further investigate Hedgehog pathway activation, we measured GLI3 processing in 
affected and control fibroblasts stimulated with SAG and quantified the ratio of GLI3 full-
length (GLI3FL) to re-pressor (GLI3R) forms by Western blot analysis. We found that this 
ratio is increased two to three fold in DYNC2LI1-mutant fibroblasts as compared with 
control cells (Fig. 7d,e). An increased ratio of GLI3FL to GLI3R suggests impaired 
proteolytic processing of GLI3, which has been proposed to be the underlying cause for the 
polydactyly commonly seen in SRPS and other ciliopathies42. In addition, total GLI3 was 
markedly increased in unstimulated DYNC2LI1-mutant fibroblasts, implying that not only is 
processing altered but the total amount of available GLI3 is abnormal as well (Fig. 7d,f). To 
test whether this altered ratio had functional consequences on transcription of Hedgehog 
targets, we performed quantitative RT-PCR of PTCH1 and GLI1 on control and SRPS 
fibroblasts. We found that both control and SRPS cells responded to SAG with an increase 
in PTCH1 and GLI1 cDNA (Supplementary Fig. 5), suggesting that in these cells, the loss of 
the dynein-2 complex stability does not completely impair their ability to respond to SAG. 
Yet, altered GLI3FL to GLI3R ratios, together with the abnormal distribution of SMO into 
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cilia of unstimulated SRPS cells, support impaired regulation of Hedgehog signaling in cells 
from SRPS cases with DYNC2LI1 mutations.
Discussion
We show that DYNC2LI1 mutations cause SRPS, expanding the number of genes associated 
with this condition. The phenotypic findings in these SRPS cases are similar to those seen in 
cases with DYNC2H136 and WDR3413 mutations, supporting that these proteins are part of 
the same complex. Using SRPS fibroblasts we show that DYNC2LI1 mutations result in loss 
of cilia length regulation, ciliary accumulation of IFT components, and aberrant Hedgehog 
pathway activity. Rescue of mutant fibroblasts with human DYNC2LI1 corrected the cilia 
phenotype, directly confirming that the changes in cilia length and IFT resulted from the loss 
of normal DYNC2LI1.
Our findings demonstrate that DYNC2LI1 is involved in both the repression of Hedgehog 
activity in the absence of stimulation and the activation of Hedgehog in response to 
stimulation. Alterations to Hedgehog signaling due to mutations in IFT-A proteins are 
typically mediated by either changes in cilia structure or trafficking, as opposed to non-
ciliary functions of these proteins43. In the absence of stimulation, SMO is actively excluded 
from the cilia and GLI3 is processed into its repressor form. We show that SMO 
inappropriately enters the cilium in the absence of SAG stimulation in SRPS but not in 
control cells (Fig. 7b). This abnormal ciliary localization of SMO has been seen in other IFT 
mutants as well, including DYNC2H141 and ICK44, and is suggestive of inappropriate 
Hedgehog pathway activation. Whether this SMO is active or not remains to be determined, 
however the deficient processing of GLI3 into the repressor form suggests the former in 
DYNC2LI1-mutant fibroblasts (Fig. 7d,e). We observed that DYNC2LI1-mutant SRPS cells 
exhibit increased amounts of GLI3FL with and without stimulation, increased ratios of 
GLI3FL to GLI3R, and decreased amounts of GLI3R upon stimulation as compared with 
controls. However, we could not identify a grossly abnormal transcriptional response in 
SRPS cells. This suggests that these cells can at least partially respond to Hedgehog 
signaling, though the in-vivo consequences of persistent altered GLI3FL to GLI3R amounts 
in certain tissues, particularly in a temporal manner, may underlie developmental 
abnormalities, particularly polydactyly, as seen in these SRPS cases.
We found that mutations in DYNC2LI1 do not preclude cilia formation, but rather cause cilia 
length dysregulation. Based on the phenotype of most mutants with diminished capacities 
for retrograde transport, including dynein-2 complex mutants, it is interesting that cilia in 
DYNC2LI1 mutants are longer than those in controls. In Chlamydomonas, dynein-2 null 
mutants (dhc1b21; stf-1, stf-222) have short, bulbous cilia with an accumulation of IFT-B 
components at their tips, suggesting an essential role for dynein-2 in recycling ciliary 
components back to the cell body. As IFT-B accumulates in these mutants, exhausting the 
pool of kinesin-2, the cilium loses its ability to grow or even maintain its length. In contrast, 
the DYNC2LI1-mutant SRPS cases reported here have pronounced losses of both 
DYNC2H1 and DYNC2LI1 yet display robust ciliogenesis with longer-than-average cilia, 
despite having the characteristic IFT-B accumulations. This is similar to dynein-2 mutants in 
Tetrahymena (KO-D2LIC)45. It is thus likely that the DYNC2LI1 mutations alter the 
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functioning of the dynein-2 complex without abolishing function altogether. The main 
defect in these cells appears to be loss of cilia length regulation as is evidenced by large 
variations in cilia lengths. It is possible that the small amount of remaining normal 
DYNC2H1 is enough to prevent the IFT congestion and stunted cilia seen in other 
mutants46. We therefore conclude that the residual activity of the dynein-2 complex in 
DYNC2LI1-mutant fibroblasts was enough to support robust ciliogenesis but insufficient to 
ensure the correct regulation of primary cilium size.
While we have shown that mutations in DYNC2LI1 produce a severe skeletal dysplasia, little 
is known regarding the expression of this gene in distinct tissues. Quantitative RT-PCR from 
RNA derived from a series of 16-week fetal tissues showed that DYNC2LI1 is expressed in 
all tissues studied, but is highest in bone (Supplementary Fig. 3). Furthermore, the dynein-2 
complex proteins we evaluated localized to the perichondrium/periosteum and primary 
spongiosa of bone (Fig. 4), suggesting an important role in the developing skeleton. These 
regions have been shown to be important for signaling and organization of a normal 
cartilage growth plate47, 48. The primary spongiosa, in particular, was reported to be 
irregular in SRPS cases with DYNC2H1 mutations4 with loss of degradation of the 
mineralized hypertrophic zone, supporting the potential role of the dynein-2 complex in 
orchestrating the development of normal endochondral bone formation. Localization of the 
dynein-2 complex to the cartilage growth plate begins to provide insight into the reasons for 
altered endochondral ossification that are seen in SRPS.
In summary, our findings establish the clinical and cellular consequences of DYNC2LI1 
mutations and dynein-2 complex disruption in human primary cells, and support the 
profound importance of this protein complex in proper skeletogenesis.
Methods
Exome sequencing
Under an approved University of California at Los Angeles human subjects protocol, DNA 
was isolated and submitted to the University of Washington Center for Mendelian Genomics 
for library preparation and exome sequencing. The samples were barcoded, captured using 
the NimbleGen SeqCap EZ Exome Library v2.0 probe library targeting 36.5Mb of genome, 
and sequenced on the Illumina GAIIx platform with 50 bp reads. Novoalign was used to 
align the sequencing data to the human reference genome [NCBI build 37] and the Genome 
Analysis Toolkit (GATK)49 was used for post-processing and variant calling according to 
GATK Best Practices recommendations50, 51. Average coverage of targeted bases was 
103X, 61X, and 56X for R01-013A, R07-627A, and R03-303A, respectively. For each 
sample, at least 90% of targeted bases were covered by at least 10 independent reads. 
Variants were filtered against dbSNP137, 95 NIEHS EGP exome samples (v.0.0.8), 6503 
exomes from the NHLBI Exome Sequencing Project (ESP6500), 1000 genomes (release 
3.20120430), and 40 in-house exome samples. Mutations were further compared with 
known disease-causing mutations in HGMD (2012.2). Variants were annotated using 
VAX52 and mutation pathogenicity was predicted using the programs Polyphen53, Sift54, 
Condel55, and CADD56. The mutations reported in this work were confirmed by 
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bidirectional Sanger sequencing of amplified DNA from the proband and available parents 
(Supplementary Fig. 1). Primer sequences used were:
DYNC2LI1-ex6 F’: TTTTTGTTTTTGGGAGTCTTAGAA 
R’:TTGCTGTAATTTTCCAGTGAACA
DYNC2LI1-ex12 F’: ACCTGGCAGAATTGGAAGTG R’: 
GGTGGGATGACAGGTGATTT
DYNC2LI1-ex13 F’: GTGCTGCTTAGCCACACAGA R’: 
GTGGGCACTTAACCTTGCAT
Sequence trace files were aligned and analyzed using Geneious version 7.1.4 created by 
Biomatters (http://www.geneious.com/).
The samples were part of a larger cohort of SRPS samples submitted for the purpose of 
identifying novel disease genes and characterizing the incidence of mutations in known 
genes. The cohort had not been previously tested for mutations in known SRPS-causing 
genes.
Filtering Strategy
We prioritized mutations predicted to affect protein function (insertions or deletions, 
frameshifts, non-synonymous mutations, and essential spice site mutations). We later 
included highly conserved splice region variants, allowing us to discover the DYNC2LI1 +3 
splice site mutation. We prioritized mutations that had not been previously seen in the 
homozygous state in control databases and mutations with a minor allele frequency < 0.005. 
Due to the recessive inheritance of SRPS, we looked for genes in which both alleles were 
potentially mutated. DYNC2LI1 stood out as a potential gene due to the incidence of unique, 
compound heterozygous mutations in three families in which the SRPS cases had strikingly 
similar X-ray features.
RT-PCR
RNA from SRPS case and control fibroblast cell lines was extracted using TRIZOL 
(Invitrogen 15596). RT-PCR was performed using SuperScript III One Step Kit (Invitrogen 
12574-018) with the following DYNC2LI1 primers targeting a 431 bp template spanning 
exon 12: F’: CGCTGTTTATCACAGCAGGA R’: CCAAGAAATCCAGCTTGTCC. An 
amplified fragment of 431 bp corresponds to the wild-type RNA and a fragment of 339 bp 
corresponds to a transcript missing exon 12.
Quantitative RT-PCR
Total RNA was extracted from a series of 16-week fetal tissues as well as from control, 
R01-013A and R07-628A fibroblasts (with and without SAG treatment) using TRIZOL 
(Invitrogen 15596). cDNA was treated with DNAase (Invitrogen 18068) and reversed 
transcribed (Thermo Scientific K1621) according to the manufacturer’s instructions. 
Quantitative RT-PCR was performed with a real-time PCR detection system (Stratagene 
MX3005P) using SYBR green PCR master mix (Thermo Scientific K0222) and standard 
thermocycler conditions. qRT-PCRs were performed in triplicate in a total volume of 25 μl 
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for 3 independent replicates. Each sample was analyzed for two housekeeping genes to 
normalize for RNA input amounts and to perform relative quantifications. Levels of 
transcripts in controls were set at 1. Melting curve analysis showed a single, sharp peak with 
the expected melting temperature for all samples. RT-PCR primers sequences were as 
follows:
DYNC2LI1 F’: GAAGGTGATGGAGCTGAAATTG R’: GTATATTCCAAAGCTAAGGTTGGTT
YWHAZ F’: CAGCAGATGGCTCGAGAATA R’: GAAGCATTGGGGATCAAGAA
BACT F’: TCCCTGGAGAAGAGCTACGA R’: AGGAAGGAAGGCTGGAAGAG
PTCH1 F’: ACTCTGCTGGGAGTGCTGAT R’: AAAACCAGCCCATTGAGAAC
GLI1 F’: ACACCGGTACCACTGTGTCC R’: CGGCTGACAGTATAGGCAGA
GAPDH F’: CGTAGCTCAGGCCTCAAGAC R’: GCTGCGGGCTCAATTTATAG
GUSB F’: CGAATCACTATCGCCATCAA R’: CCCTTGGGATACTTGGAGGT
Molecular cloning of DYNC2LI1
Human DYNC2LI1 cDNA (NM_016008.3) was synthesized using gBlock from IDT. The 
cDNA was flanked by XhoI and NotI restriction sites, which were used for insertion into 
pCAGIG, a pCAG-IRES-GFP vector (a gift from Connie Cepko (Addgene plasmid 
#11159)). The final construct was then used to express both untagged DYNC2LI1 and GFP 
in SRPS fibroblasts for the rescue experiments.
Cell culture
Unless otherwise stated, control and SRPS human fibroblasts from patients were grown in 
DMEM supplemented with 10% FBS, 1% Penicillin/Streptomycin/L-Glutamine and were 
maintained at 37°C with 5% CO2.
For serum starvation and to promote ciliogenesis, cells were washed in PBS and incubated 
with serum-free media (or supplemented with 0.5% FBS) for 48 hrs. For stimulation of the 
sonic hedgehog pathway, serum-free media was supplemented with 500 nM SAG 
(Calbiochem 566660) for 24–48 hrs before cell fixation. hTERT-RPE1-GFP-CSAP cells (a 
kind gift from I. Cheeseman)57 were grown in DMEM/F12 supplemented with 10% FBS, 
1% Penicillin/Streptomycin and were maintained at 37°C with 5% CO2.
Rescue experiments
Transfections of SRPS fibroblasts with hDYNC2LI1 IRES GFP were performed using 
Amaxa Kit for Primary Mammalian Fibroblasts according to manufacturer’s instructions 
and program T-16. 24 hrs following transfection, cells were washed in PBS and incubated 
with serum-free media for an additional 48 hrs.
RNAi
For RNA-mediated interference, siGENOME (51626) Human DYNC2LI1 siRNA smartpool 
(Dharma-con) was employed against the following target sequences:
5’-GGAAUAAUAUGCCGAAGGA-3’
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5’-CAAAAGAUAUCGCUCACUU-3’
5’-CCAUGUAGACAAAGUGAUA-3’
5’-GGAAAGACUACUAUUAUUC-3’.
Non-targeting siRNA was used as a control. RNAi was carried out using the Hiperfect 
reagent (Qiagen), according to manufacturer’s instructions. 48 hrs following RNAi 
transfection, hTERT-RPE1-GFP-CSAP cells57 (RPE1 cells with ciliary axoneme and 
centrioles marked by CSAP) were washed in PBS and incubated with an additional round of 
RNAi in serum-free media for 48 hrs to induce ciliogenesis. Knockdown was confirmed by 
Western blotting.
Immunofluorescence—Cells were seeded into 4-well chamber slides (LabTek) at a 
density of 4 x 104 cells per well and allowed to adhere overnight. After serum starvation, 
cells were washed twice with PBS and fixed in 95% methanol with 5 mM EGTA (pre-
chilled to -20°C) for 5 min. Alternatively, cells were fixed in 4% PFA for 15 min at room 
temperature, washed, and then permeabilized with 0.1% Triton-X-100 in PBS for 5 min at 
room temperature. After extensive washing, cells were blocked in PBS containing 5% serum 
for 1 hr at room temperature. Primary antibodies were diluted in PBS containing 1–5% 
serum. Cells were incubated with the following primary antibodies for 1 hr at room 
temperature or overnight at 4°C: rabbit anti-WDR34 (1:200; Abcam ab81030), rabbit anti-
DYNC2H126 (1:150; Dynein HC2), rabbit anti-ARL13B (1:150; Proteintech 17711-1-AP), 
rabbit anti-IFT88 (1:150; Proteintech 13967-1-AP), rabbit anti-KIF3A (1:150; Sigma-
Aldrich K3513), rabbit anti-TRAF3IP1 (1:100; Pierce PA5-30507), mouse anti-acetylated β-
tubulin (1:2,000; 6-11B-1; Sigma-Aldrich T6793), rabbit anti-acetylated β-tubulin (1:800; 
D20G3; Cell Signaling Technology #5335), mouse anti-polyglutamylated tubulin (GluTUB) 
(1:300; Adipogen GT335), SMO (1:300; a kind gift from K. Anderson), and goat anti-GLI3 
(10 μg mL-1; R&D Systems AF3690). After extensive washing, cells were incubated for 1 hr 
at room temperature with Alexa Fluor 488/ 568-conjugated secondary antibodies (1:400; 
Invitrogen and Jackson ImmunoResearch) in PBS containing 5% serum. For rescue 
experiments in Figs. 5d and 6b, Cy5- and Cy3-labeled secondary antibodies (1:400; Jackson 
ImmunoResearch) were used to detect ARL13B/IFT88 and GluTUB, respectively. Images 
were captured on an IX80 laser scanning confocal microscope (Olympus FV100 Spectral 
Confocal System) or a Leica Confocal TCS-SP2 using a 100x 1.40 N.A. or a 63X (oil) 
objective 1.2 N.A. Images were collected with 1024x1024 pixel definition and Z-sections 
were taken at 0.5 μm step size. Max projections of the Z-stacks were used for primary cilium 
measurement and counting in ImageJ (NIH). To assess the impact of DYNC2LI1 mutations 
on ciliogenesis, we examined the localization of the ciliary membrane and axoneme markers 
ARL13B and glutamylated tubulin. ARL13B is a membrane protein belonging to the Arf 
family of GTPases that constitutively localizes to cilia. ARL13B signal is dispersed in the 
cytoplasm if a cell does not have a cilium, which allowed us to confidently score the 
percentage of ciliated cells when co-staining with an axonemal marker. Tubulin acetylation 
and glu-tamylation58 are post-translational modifications associated with stable microtubule 
structures such as the cilia axoneme and, for glutamylated tubulin, the basal body and other 
centrioles.
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Quantification of IFT88 retention in the distal end of primary cilia was performed in similar-
sized primary cilia using ImageJ (NIH). Polyglutamylated tubulin staining of centrioles and 
the proximal end of the axoneme served to determine the orientation of each primary cilium, 
allowing for the measurement of IFT88 signal intensity in the proximal end and in the 
remaining body of each primary cilium. After determining the ratio of IFT88 signal in each 
primary cilium, the resulting values were used to determine the average ratio of IFT88 signal 
for each experiment. Statistical analyses were performed with Prism v 5.0 (GraphPad).
Immunohistochemistry
A human humerus from a 14-week fetus was fixed in PFA and decalcified with Immunocal 
for 2 days. After decalcification, samples were embedded in paraffin and 10 μm sections 
were prepared. Sections were treated with citrate buffer for antigen retrieval and quenched 
by peroxidase solution for 10 min each. Primary antibodies used were: rabbit anti-
DYNC2LI126 (1:200; LIC3), rabbit anti-WDR34 (1:150; Sigma HPA041091) and rabbit 
anti-DYNC2H126 (1:150; Dynein HC2). After primary incubation, a Histostain Plus kit 
(Invitrogen 85-9243) was used for development with DAB.
Protein/Western blot analysis
Cells were lysed in 1X RIPA Buffer (Cell Signaling Technology) supplemented with 1 mM 
PMSF and a protease inhibitor cocktail (Sigma-Aldrich). Lysates were cleared by 
centrifugation (10 min at 16,000 x g at 4ºC). 20–80 μg of protein per sample was loaded 
onto 10% or gradient SDS-polyacrylamide gels and separated by electrophoresis. Proteins 
were transferred to PVDF or nitrocellulose membranes, which were then blocked with 5% 
milk for 1 hr at room temperature. Membranes were then probed with primary antibodies 
diluted in 1–5% milk or BSA for 3 hrs at room temperature or overnight at 4°C: rabbit anti-
DYNC2LI126 (1:200; LIC3), rabbit anti-WDR34 (1:200; Abcam ab81030), rabbit anti-
DYNC2H126 (1:150; Dynein HC2), rabbit anti-GAPDH (1:1,000; 14C10; Cell Signaling 
Technology #2118), mouse anti-β-tubulin (1:10,000; GTU-88; Abcam ab11316), mouse 
anti-β-tubulin (1:5000; Sigma T9026), and goat anti-GLI3 (1 μg mL-1; R&D Systems 
AF3690). After extensive washing, membranes were incubated with HRP-conjugated or 
fluorescent secondary antibodies and the signal was captured on film or in an Odyssey 
system (Licor). Protein amounts were quantified from scanned blots using ImageJ (NIH). 
Full scans of Western blot data are included in Supplementary Fig. 6.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Mutations in DYNC2LI1 cause short rib polydactyly syndrome. Radiographs of the affected 
probands, R03-303A, R01-013A and R07-628A (International Skeletal Dysplasia Registry 
reference numbers) showing short long bones, horizontal ribs and long narrow chest, poor 
mineralization of some skeletal elements (single arrow), metaphyseal irregularity (double 
arrows), and polydactyly in all the limbs of the affected individuals.
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Figure 2. 
Effect of DYNC2LI1 mutations on splicing and protein stability. (a) RT-PCR of cDNA 
derived from control and SRPS fibroblasts shows that DYNC2LI1 splice-donor mutations 
cause in-frame skipping of exon 12. (b) Immunoblotting reveals significant reduction in the 
amounts of DYNC2LI1 from lysates of affected cells compared with control. Size markers 
(right, kDa), β-tubulin, loading control. (c) Quantification of average DYNC2LI1 amounts 
from (b) for each genotype. Values were normalized to control and error bars represent ± 
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s.e.m (3 independent experiments). Statistical analyses performed using the Mann-Whitney 
test, p<0.05 labeled with *.
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Figure 3. 
Mutations in DYNC2LI1 decrease the stability of DYNC2H1. (a) Immunoblotting for 
components of the dynein-2 complex (heavy chain, DYNC2H1; intermediate chain, 
WDR34) and the heavy chain of the dynein-1 complex (DYNC1H1) reveals a specific 
reduction of DYNC2H1. (b) Immunofluorescence micrographs of control and SRPS cells 
stained for GluTUB (red) and WDR34 (green) or DYNC2H1 (green). Cilia (2x) are shown 
on the right. Scale bar = 5 μm.
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Figure 4. 
Components of the dynein-2 complex are co-expressed in a human cartilage growth plate. 
(a) Sections from a 14-week human humerus were stained for DYNC2LI1, DYNC2H1 and 
WDR34. All three proteins were expressed in the perichondrium/periosteum and primary 
spongiosa (closed arrows, perichondrium/periosteum; open arrows, primary spongiosa). 
Scale bar = 50 μm.
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Figure 5. 
Primary cilia are variable in length and longer in DYNC2LI1-mutant cells. (a) 
Immunofluorescence micrographs of serum-starved control and SRPS fibroblasts stained for 
ARL13B (green), GluTUB (red) and Hoescht (blue) show variable length and 
hyperelongated cilia in SRPS cells. (b) Percentage of ciliated cells in (a) (n=150 X 3 
independent experiments). (c) Primary cilia length is highly variable in cells with 
DYNC2LI1 mutations (n>20 X 3 independent experiments). (d) Expression of untagged wild 
type DYNC2LI1 through an IRES-GFP vector (artificially colored blue) rescues cilia length 
variability in SRPS cells. Error bars represent ± s.e.m. Statistical analyses performed using 
Mann-Whitney test, p<0.05 values labeled with *. Scale bar = 5 μm.
Taylor et al. Page 20
Nat Commun. Author manuscript; available in PMC 2015 December 16.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Figure 6. 
DYNC2LI1 mutations delay retrograde IFT and lead to the ciliary accumulation of IFT 
components. (a) Immunofluorescence micrographs of control and SRPS cells stained as 
labeled. Cilia (2x) are shown on the right. (b) Expression of untagged wild type DYNC2LI1 
through an IRES-GFP vector (artificially colored blue) rescues ciliary accumulation of IFT 
components. (c) Quantification of IFT88 signal: graph shows the mean ratio of IFT88 signal 
between the cilium body and its proximal end ± s.e.m (n=20 X 3 independent experiments). 
Statistical analyses performed using Mann-Whitney test, p<0.05 values labeled with *. Scale 
bar = 5 μm.
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Figure 7. 
Disruption of the dynein-2 complex leads to aberrant Hedgehog signaling. (a) 
Immunofluorescence micrographs of control and SRPS cells treated with SAG and stained 
for GLI3 (red), AcTUB (green), and DAPI (blue). (b) DYNC2LI1/dynein-2 complex 
activity is required for the exclusion of SMO from the primary cilium in the absence of 
Hedgehog stimulation. Immunofluorescence micrographs of SAG-stimulated control and 
SRPS cells stained for SMO (green) and GluTUB (red). (c) Graph shows the mean 
percentage of ciliated cells with ciliary SMO ± s.e.m. (>100 cells counted X 3 independent 
experiments). (d) Immunoblotting for GLI3 (full length “GLI3FL”; repressor “GLI3R”) in 
cell extracts shows increased GLI3FL to GLI3R in SRPS cells. (e) Graph shows the ratio of 
GLI3FL to GLI3R. (f) Graph shows quantification of total GLI3 amounts (GLI3FL + 
GLI3R) which is increased in DYNC2LI1-mutant fibroblasts. Statistical analyses performed 
using Mann-Whitney test, p<0.05 is labeled with *. Scale bars = 5 μm.
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